These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26763336)

  • 1. Role of vaccination-induced immunity and antigenic distance in the transmission dynamics of highly pathogenic avian influenza H5N1.
    Sitaras I; Rousou X; Kalthoff D; Beer M; Peeters B; de Jong MC
    J R Soc Interface; 2016 Jan; 13(114):20150976. PubMed ID: 26763336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Sitaras I; Rousou X; Peeters B; de Jong MCM
    Vaccine; 2016 Nov; 34(46):5512-5518. PubMed ID: 27729175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    Tarigan S; Wibowo MH; Indriani R; Sumarningsih S; Artanto S; Idris S; Durr PA; Asmara W; Ebrahimie E; Stevenson MA; Ignjatovic J
    PLoS One; 2018; 13(1):e0190947. PubMed ID: 29320563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens.
    Tarigan S; Indriani R; Durr PA; Ignjatovic J
    Avian Pathol; 2015; 44(4):259-68. PubMed ID: 25915110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
    Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1.
    Cornelissen LA; de Vries RP; de Boer-Luijtze EA; Rigter A; Rottier PJ; de Haan CA
    PLoS One; 2010 May; 5(5):e10645. PubMed ID: 20498717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus.
    Sasaki T; Kokumai N; Ohgitani T; Sakamoto R; Takikawa N; Lin Z; Okamatsu M; Sakoda Y; Kida H
    Vaccine; 2009 Aug; 27(38):5174-7. PubMed ID: 19596414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus.
    Swayne DE; Lee CW; Spackman E
    Avian Pathol; 2006 Apr; 35(2):141-6. PubMed ID: 16595307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.
    Hassan MK; Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Samy A; Samir M; Le Brun Y; Jobre Y; Aly MM
    Arch Virol; 2012 May; 157(5):951-9. PubMed ID: 22350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
    Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
    Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular vaccination with an inactivated highly pathogenic avian influenza virus induces protective antibody responses in chickens.
    Hikono H; Mase M; Matsuu A; Nakayama M; Saito T
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):83-9. PubMed ID: 23159237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different counteracting host immune responses to clade 2.2.1.1 and 2.2.1.2 Egyptian H5N1 highly pathogenic avian influenza viruses in naïve and vaccinated chickens.
    Samy AA; El-Enbaawy MI; El-Sanousi AA; Nasef SA; Naguib MM; Abdelwhab EM; Hikono H; Saito T
    Vet Microbiol; 2016 Feb; 183():103-9. PubMed ID: 26790942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens.
    Rudolf M; Pöppel M; Fröhlich A; Breithaupt A; Teifke J; Blohm U; Mettenleiter T; Beer M; Harder T
    Vaccine; 2010 Oct; 28(42):6832-40. PubMed ID: 20727963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens.
    Poetri ON; Bouma A; Murtini S; Claassen I; Koch G; Soejoedono RD; Stegeman JA; van Boven M
    Vaccine; 2009 May; 27(21):2864-9. PubMed ID: 19428896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.